查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991594

全球體外膜氧合（ECMO）設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Extracorporeal Membrane Oxygenation Machine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 161 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計體外膜氧合（ECMO）設備的市場規模將從 2025 年的 3.8302 億美元成長到 2034 年的 6.5374 億美元，並預計從 2026 年到 2034 年將以 6.12% 的複合年成長率成長。

由於重症監護領域對先進生命維持系統的需求不斷成長，體外膜氧合（ECMO）設備的全球市場正穩步成長。 ECMO設備透過在體外為血液供氧，為嚴重心臟衰竭衰竭患者提供臨時生命支持。這些設備通常用於加護病房以及複雜的心臟和呼吸治療。

該市場的主要促進因素是嚴重呼吸系統和心血管疾病發生率的不斷上升。體外膜氧合（ECMO）在急性呼吸窘迫症候群（ARDS）等嚴重的應用日益廣泛，顯著擴大了其在醫院的部署。此外，醫療技術的進步和病患監測系統的改進也提高了ECMO治療的安全性和有效性。

隨著醫療系統加大對先進緊急醫療技術的投資，體外膜氧合（ECMO）設備市場預計將持續成長。生命維持設備的持續研發將提升設備性能並改善患者預後。此外，醫療基礎設施的擴建和醫護人員培訓的加強也有望推動市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球體外膜氧合（ECMO）設備市場：依組件分類

  • 市場分析、洞察與預測
  • 泵浦
  • 氧合器
  • 控制器
  • 套管
  • 配件

第5章 全球體外膜氧合（ECMO）設備市場：依治療方法分類

  • 市場分析、洞察與預測
  • 靜脈 - 動脈
  • 靜脈-靜脈
  • 動脈-靜脈

第6章 全球體外膜氧合（ECMO）設備市場：依應用分類

  • 市場分析、洞察與預測
  • 呼吸系統
  • 為了心
  • ECPR

第7章 全球體外膜氧合（ECMO）設備市場：依病患類型分類

  • 市場分析、洞察與預測
  • 新生
  • 兒童
  • 成人

第8章 全球體外膜氧合（ECMO）設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Maquet Holding
    • Microport Scientific Corporation
    • Terumo Cardiovascular System Corporation
    • Medos Medizintechnik
    • Nipro Medical Corporation
    • LivaNova PLC
    • CytoSorbents Corporation
    • Eurosets SRL
簡介目錄
Product Code: VMR11216884

The Extracorporeal Membrane Oxygenation Machine Market size is expected to reach USD 653.74 Million in 2034 from USD 383.02 Million (2025) growing at a CAGR of 6.12% during 2026-2034.

The global extracorporeal membrane oxygenation (ECMO) machine market is growing steadily due to the increasing demand for advanced life-support systems in critical care settings. ECMO machines provide temporary support for patients with severe heart or lung failure by oxygenating the blood outside the body. These devices are commonly used in intensive care units and during complex cardiac or respiratory treatments.

A key driver of this market is the rising incidence of severe respiratory and cardiovascular diseases. The increased use of ECMO during critical conditions such as acute respiratory distress syndrome has significantly expanded its adoption in hospitals. Additionally, advancements in medical technology and improved patient monitoring systems are enhancing the safety and effectiveness of ECMO treatments.

Looking ahead, the ECMO machine market is expected to grow as healthcare systems invest in advanced critical care technologies. Continuous research and development in life-support equipment will improve device performance and patient outcomes. Expanding healthcare infrastructure and increased training for healthcare professionals are also expected to support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

By Modality

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Patient Type

  • Neonates
  • Pediatric
  • Adult

COMPANIES PROFILED

  • Medtronic Plc, Maquet Holding, Microport Scientific Corporation, Terumo Cardiovascular System Corporation, Medos Medizintechnik, Nipro Medical Corporation, LivaNova PLC, CytoSorbents Corporation, Eurosets SRL
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY COMPONENT 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Oxygenator Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.4. Controllers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.5. Cannula Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY MODALITY 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Modality
  • 5.2. Veno-Arterial Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Veno-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Arterio-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. ECPR Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY PATIENT TYPE 2022-2034 (USD MN and K Units)

  • 7.1. Market Analysis, Insights and Forecast Patient Type
  • 7.2. Neonates Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 7.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 7.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY REGION 2022-2034 (USD MN and K Units)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.2.1 By Component
    • 8.2.2 By Modality
    • 8.2.3 By Application
    • 8.2.4 By Patient Type
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.3.1 By Component
    • 8.3.2 By Modality
    • 8.3.3 By Application
    • 8.3.4 By Patient Type
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.4.1 By Component
    • 8.4.2 By Modality
    • 8.4.3 By Application
    • 8.4.4 By Patient Type
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.5.1 By Component
    • 8.5.2 By Modality
    • 8.5.3 By Application
    • 8.5.4 By Patient Type
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.6.1 By Component
    • 8.6.2 By Modality
    • 8.6.3 By Application
    • 8.6.4 By Patient Type
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Medtronic Plc
    • 10.2.2 Maquet Holding
    • 10.2.3 Microport Scientific Corporation
    • 10.2.4 Terumo Cardiovascular System Corporation
    • 10.2.5 Medos Medizintechnik
    • 10.2.6 Nipro Medical Corporation
    • 10.2.7 LivaNova PLC
    • 10.2.8 CytoSorbents Corporation
    • 10.2.9 Eurosets S.R.L